This site is intended for healthcare professionals
News

Gilead Sciences acquires Immunomedics and with it, Trodelvya treatment for triple negative breast cancer

Read time: 1 mins
Last updated:15th Sep 2020
Published:15th Sep 2020
Type: industry
Register free for full access to medthority.com